Pricing Log in Create free account
Friday 6 November 2026 Export BRKR’s income statement to Excel — free account

Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

61.20 3.14 +5.41%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.34%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bruker Corporation (BRKR) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Bruker Corporation (BRKR) trades at a EV/Sales of 3.0×. Over the past ten years it has ranged from 1.6× (October 2015) to 6.2× (September 2021); the current reading is higher than 46% of that period. That is above the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.5× (19.74%)
FY2024 3.2× (17.61%)
FY2023 3.8× (10.38%)
FY2022 4.3× (19.55%)
FY2021 5.3× 25.70%
FY2020 4.2× 9.18%
FY2019 3.9× 57.48%
FY2018 2.5× (19.96%)
FY2017 3.1× 46.07%
FY2016 2.1× (11.83%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.3× 5.73%
Jun 2026 3.1× 51.78%
Mar 2026 2.0× (19.85%)
Dec 2025 2.5× 31.29%
43 more quarters

Against its own ten years

Low 1.6× High 6.2×
Ten-year median 3.1×
Current reading's percentile 41

EV/Sales against peers

Company EV/Sales
SNN Smith & Nephew SNATS, Inc. compare 1.6×
BRKR Bruker Corporation 3.0×
PODD Insulet Corporation compare 3.5×
GMED Globus Medical, Inc. compare 3.5×
BIO Bio-Rad Laboratories, Inc. compare 3.7×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
PEN Penumbra, Inc. compare 7.7×
TXG 10x Genomics compare 11.5×
GKOS Glaukos Corporation compare 18.8×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BRKR